Proteomics + Lipidomics + Metabolomics:BET inhibitors: affected AR+ PCa (22RV1, LNCaP, VCaP) more than AR- PCa (PC3, DU145).BET inhibitors → disrupted AR and MYC signaling at concentrations: (BET) < (BET inhibitors) (Proteomics). The gene discussed is MYC; the disease is posterior cortical atrophy.